Farther Finance Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$193K Buy
16,596
+2,641
+19% +$37.7K ﹤0.01% 2261
2026
Q1
$225K Buy
13,955
+4,010
+40% +$71.7K ﹤0.01% 1938
2025
Q4
$159K Buy
9,945
+6,033
+154% +$89.8K ﹤0.01% 2060
2025
Q3
$48.4K Buy
3,912
+43
+1% +$504 ﹤0.01% 2460
2025
Q2
$44.6K Sell
3,869
-19,997
-84% -$237K ﹤0.01% 2191
2025
Q1
$358K Hold
23,866
0.01% 950
2024
Q4
$413K Hold
23,866
0.01% 665
2024
Q3
$442K Sell
23,866
-1,718
-7% -$34.5K 0.02% 642
2024
Q2
$511K Buy
25,584
+5,718
+29% +$101K 0.02% 473
2024
Q1
$340K Buy
19,866
+13,197
+198% +$208K 0.02% 488
2023
Q4
$118K Buy
6,669
+2,669
+67% +$53.8K 0.01% 736
2023
Q3
$96K Hold
4,000
0.02% 573
2023
Q2
$93K Hold
4,000
0.02% 487
2023
Q1
$88.2K Buy
+4,000
New +$93.6K 0.03% 435

Other funds holding CLB

Farther Finance Advisors's CLB Position: Q2 2026 in Review

Farther Finance Advisors increased its Core Laboratories (CLB) stake by 19% in Q2 2026, buying an estimated $37.7K and bringing the position to 16,596 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #2261.

Farther Finance Advisors first reported a position in CLB in Q1 2023 and has held it in 14 quarters since. The position peaked at $511K in Q2 2024. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Farther Finance Advisors held 16,596 shares of Core Laboratories worth $193K as of Q2 2026.
  • Farther Finance Advisors bought 2,641 Core Laboratories shares in Q2 2026, an estimated $37.7K.
  • Core Laboratories made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #2261 holding.
  • Farther Finance Advisors first reported a position in Core Laboratories in Q1 2023 and has held it in 14 quarters since.
  • Farther Finance Advisors's Core Laboratories position peaked at $511K in Q2 2024.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.